Alan E. Smith, Senior VP, Chief Scientific Officer at GENZYME CORP (GENZ), sold 4,789 shares at $45.63 ($219K) on 2010-05-25, disclosed to the SEC on 2010-05-26.
Open-market sale of $219k GENZ by Senior VP, Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $45.62 | 1,197 | $55K | 25.0% |
| 2 | $45.63 | 3,592 | $164K | 75.0% |
| Total | $45.63 avg | 4,789 | $219K | 100% |
| Filing → |
| GHM | BUY | 2020-03-06 | $13K | — | Filing → |
| GHM | SELL | 2018-06-05 | $347K | — | Filing → |
| GHM | SELL | 2017-03-07 | $12K | — | Filing → |